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Background: The project aims were to evaluate the benefit of transmucosal Midazolam 
0.2mg/kg pre-medication on anxiety, induction behaviour and psychological morbidity 
in children undergoing general anaesthesia (GA) extractions.  
Method: 179 children aged 5-10 years (mean 6.53 years) participated in this 
randomised, double blind, placebo controlled trial.  Ninety children had Midazolam 
placed in the buccal pouch.  Dental anxiety was recorded pre operatively and 48 hours 
later using a child reported MCDAS-FIS scale.  Behaviour at anaesthetic induction was 
recoreded and psychological morbidity was scored by the parent using the Rutter Scale 
pre-operatively and again one-week later.  Subsequent dental attendance was recorded 
at one, three and six months after GA. 
 
Results: Whislt levels of ental anxiety did not reduce overall,  the most anxious patients 
demonstrated a reduction in anxiety after receiving midazolam premedicationmay 
(p=0.01).  Neither induction behaviour nor psychological morbidity improved.  
Irrespective of group, parents reported less hyperactive (p= 0.002) and more prosocial 
behaviour (p=0.002) after the procedure:;, older children improved most (p=0.048), 
Post GA Dental attendance was poor and unrelated to after the procedure and 
unaffected by premedication.. 
 
Conclusion: 0.2mg/kg buccal Midazolam provided some evidence for reducing anxiety 
in the most dentally anxious patients.  However, induction behaviour, psychological 
morbidity and subsequent dental attendance were not found to alter between the 
premedication groups. 
 
Key words: general anaesthesia; dentistry; premedication; midazolam; anaesthetic 
induction; postoperative morbidity. 
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Introduction 
The referral for dental general anaesthetic (DGA) is now deemed to be a treatment of 
‘last resort’1  for children in advanced stages of dental disease who are too anxious, or 
too immature, to undergo dental treatment by other means 2.  The prospect of the DGA 
event has been found to provoke anxiety in 56-66% of children 3.  These children are 
more dentally anxious than their peers, and their anxiety is also associated with greater 
distress at anaesthetic induction and increased post-operative morbidity 4.  
Psychological morbidity such as attention-seeking, tantrums, crying and nightmares is 
well recognised 5, 6 and is more likely in children who are younger,  have pre-existing 
behavioural problems and pre-existing dental anxiety 3, 4 
 
Midazolam is a common premedicant at anaesthetic induction and  is suggested thatto 
reduce post-anaesthesia behaviour disturbance. However, the evidence for efficacy 
varies between study populations and there is a balance between optimal therapeutic 
effect and delay of postoperative recovery 7, 8, 9.  
 
The authors have already reported that the children in this trial experienced significant 
cognitive deficit due to midazolam premedication when compared with placebo 10. This 
paper presents the data that evaluates the benefit of 0.2mg/kg Midazolam premedication 
on dental anxiety, anaesthetic induction distress, psychological morbidity and 
subsequent dental attendance.  
 
Aims 
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To evaluate the benefit of Midazolam 0.2mg/kg deposited in the buccal pouch as a pre-
medication upon child-reported dental anxiety, the observed behaviour of children at 
anaesthetic induction, post operative psychological morbidity and continued dental 
attendance. 
 
Null Hypothesis (does the BDA require this?)  
Pre-operative 0.2mg/kg midazolam will reduce neither anxiety, obstructive behaviour at 
the time of anaesthetic induction nor post operative psychological morbidity and will 
not facilitate subsequent dental attendance. 
  
Method 
A prospective, randomised placebo-controlled, double blind clinical trial (registration 
number ISRCTN: 12026431; CTA 8000/13014) was conducted. Ethical approval was 
granted by the Area Ethics Committee (LREC DENTAL23; R&D ref 03DN023). 
  
Patients and recruitment 
Children aged 5 to 10 years attending Glasgow Dental Hospital and School (GDH&S) 
for extractions were invited to participate after the need for DGA had been determined 
at a previous assessment clinic. Following appropriate written consent, sampling was 
consecutive but limited by the capacity of the service and the availability of the 
research assistant (RA). Exclusion criteria included: patients who were not ASA I or II, 
those with learning disabilities, psychiatric disorder, non-fluency in English, or where 
the family had no telephone for follow-up.  
 
Recruitment took place between October 2004 and January 2006, during which time 
2495 children (aged 3-10 years) attended the service. 
 
Randomisation and blinding  
  
5 
 
The randomisation occurred at the time of the DGA visit using an automated 
computerised system.  The Research Nurse (RN) telephoned a dedicated line and 
obtained a treatment code for each subject.  The general anaesthetic staff and the RA 
remained blind until the code was broken following the completion of data collection 
and input. 
 
Premedication administration 
The RN placed the medicine in the buccal sulcus using a needle-less syringe.  The 
midazolam subjects each received 0.2mg/kg (‘Epistat’ preparation) whilst the placebo 
subjects received a similar volume prepared by the hospital pharmacy.  The placebo 
pre-medication was designed to have a similar taste, texture and colour as the Epistat 
preparation. Children were encouraged to try not to swallow the medication but to 
allow mucosal absorption to occur. Approximately thirty minutes later, anaesthesia was 
induced by inhalation of sevoflurane, nitrous oxide and 40% oxygen and maintained 
with a similar mixture using a nasal mask or, occasionally though not routinely, a 
layryngeal mask. Whilst asleep, an intravenous cannula was inserted into the child’s 
hand. The children were monitored using ECG and pulse oximeter. Before the 
extractions, lignocaine with adrenaline infiltrations were routinely injected into the 
buccal mucosa adjacent to the extraction site to reduce bleeding and to provide post-
operative pain relief. The RN remained with the child throughout the procedure and 
until the child was fully recovered and assessed as fit to discharge. 
 
Data Collection 
All data werewere collected by the RA. 
 
Demographic 
Demographic information was collected from the parent at the time of recruitment. This 
included the level of social deprivation- ‘DEPCAT’ 11. 
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Dental Anxiety 
Pre-operative: dental anxiety was assessed prior to the administration of the pre-
medicament, using the Modified Child Dental Anxiety Scale (MCDAS) augmented by 
the Facial Image Scale (FIS). The MCDAS has eight dental anxiety items. The score in 
each question may vary from 1 (relaxed) to 5 (extremely worried), thus the total score 
may range from 5 to 40 and is well validated 12, 13 .  In order to help the child confirm 
their response on the MCDAS, they were asked to indicate which facial expression on 
the FIS also corresponded to their answer (facial expressions on the FIS range from 
smiling/relaxed through neutral to worried/sad).  
 
Due to the young age of the present participants, however, it was inevitable that many 
of the children lacked experience of some of the dental procedures referred to in the 
MCDAS.  Items for which the child had no experience were therefore omitted 
completely.  Then, in order to render the scores comparable across children who 
answered different numbers of items, the average score was calculated for each child 
(i.e. the sum of the scores for each of the individual answers, divided by the total 
number of answers). The resultant average scores (ranging from 0 – 5) were used to 
allow group comparisons. 
 
It was also necessary to carry out a transformation of the MCDAS threshold scores for 
dental anxiety to equate them with the revised scoring procedure described above.  were 
excluded if children failed to understand the question, or if they had not prior 
experience of the treatmenttoThe MCDAS norms classify scores of 8.8 as ‘normal’, 
scores of over 19 as ‘anxious’ and scores of over 31 as ‘highly fearful’ 12, 13, 15.   
Transformation of these scores to a scale range of 0 to 5 results in In a score of 8.8 
isbeing equal to 1.1, a score of 19 isbeing equal to 2.4, and a score of 31 isbeing equal 
to 3.9. 
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The MCDAS-FIS was repeated, using the same method outlined above, 48 hours later 
at a home visit. 
 
Observed behaviour at anaesthetic induction 
Observed behaviour at induction was recorded using the ‘Houpt’ scale 16, 17 as shown in 
Table 1. , and was augmented with further criteria relating directly to the anaesthetic 
induction such as mask acceptance.  
 
Pre and postoperative emotional and behavioural assessment  
The well validated and reliable Revised Rutter Scale for School-Age Children 18  ,   19, 20, 
21 was completed by parents prior to premedication and at one week postoperatively by 
telephone.  This scale describes parental ratings of their children’s behavioural and 
emotional difficulties and provides both a Total Score and a score for Pro-Social 
Behaviours. In addition, the Rutter scale has sub scores for a range of behaviours 
including: Hyperactivity [range = 0-6], Conduct Difficulties [range = 0-6] and 
Emotional Disturbances [range = 0-10]. With the exception of the Pro-Social Behaviour 
score, lower scores indicate better behaviour. The Rutter scale 
 
Dental Attendance  
Dental appointments were arranged via the local Community Dental Service clinic at 
one, three and six-months after GAdischarge. 
 
Statistical analysis 
Database preparation and analysis was conducted by the University Ofof Glasgow 
Department of Statistics. The behaviour at induction was tabulated by group. The 
Rutter Scale data were analysed using the R statistics package.  Ssincludedemploying 
analysis of covariance, with linear models to examine the effects of further covariates. 
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ANCOVA was also used to assess the MCDAS-FIS scores. And significance was set at 
the 5% level. 
 
The original power calculation was based on the estimated effect of Midazolam upon 
cognitive performance, and is reported elsewhere 10.     
  
Results 
One-hundred-and-eighty-one subjects, aged 5 to 10 years (mean 6.53 years) were 
recruited. Two patients were removed from the analysis when their study codes were 
found to have been reversed leaving 179 subjects.. The CONSORT flow chart (Table 2) 
shows patient recruitment and throughput for the  One subject, from the placebo group 
was found to have contact dermatitis immediately following the DGA visit. This was 
unrelated to the premedication but she was withdrawn from post-operative follow-up. 
.One subject did not receive a general anaesthetic following premedication.  Table 3 
showing demographic and clinical patient information confirms that the midazolam and 
placebo groups were well matched.  
 
Dental Anxiety 
One hundred and thirty-eight children (n=71 Midazolam) provided data pre-operatively 
and 48 hours after GA.  Means (and standard deviations and ranges) were as follows.  
Pre-operative dental anxiety: Midazolam:  2.3, (0.78, 1.0 – 4.5) vs. placebo:  2.26 (0.78, 
1.0 – 4.6). Post-operative dental anxiety: Midazolam:  2.4 (0.69, 1.29 – 4.5) vs.  
placebo:  2.52 (0.78, 1.0 – 4.4). 
 
An ANCOVA was conducted to explore the difference in dental anxiety between 
Midazolam and placebo groups, with pre-operative scores used as a co-variant.   It was 
evident that many children had relatively low levels of pre-operative anxiety which  
would not be reduced further by Midazolam.  Therefore, analysis was restricted to 
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children scoring high in pre-operative anxiety (MCDAS baseline score >2).  These 
results demonstrateed that Midazolam pre-medication was then shown to be associated 
with a but statistically significant reduction in dental anxiety at 48 hours relative to 
placebo [estimated difference 0.31, standard error 0.12, p = 0.001].   
 
 
Observed behaviour at anaesthetic induction  
One hundred and seventy-eight children providedThere were data at anaesthetic 
induction. for 178 T.  The here was missing data for one child regarding mask 
acceptance; for another the general anaesthetic was cancelled following the premed for 
reasons unrelated to the study. When the results were tabulated (Table 1) and as no 
observable differences were shown between the Midazolam and Placebo groups.  
Therefore no further statistical analysis was undertaken.   
 
 
Pre and postoperative emotional and behavioural assessment 
Revised Rutter Scale for School Age Children: A was conducted, using age as a 
covariateapplied toscores.  There were complete data for 153 participants (Midazolam 
n=81, Placebo n=72). 
 
Total Rutter Score: AT significant effect (p=0.048) effect was observedoverall effect 
whereby children of 8 years of age and over showed a slight decrease in Rutter total 
score (i.e. improvement) at one week compared to pre-operative baseline score: 
Midazolam (n=13) change from baseline  –2.3 (5.3); Placebo (n=12) change from 
baseline –1.7 (6.6). There were no significant differences, however, as a function of 
premedication] . 
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Emotional and Conduct Rutter Subscales Scores: There were no significant changes 
from baseline to one week in either the emotional orconduct behaviours (p= 0.071 and 
p=0.214 respectively), and there was no effect of age.  
 
Hyperactive Rutter Subscale Score: The midazolam and placebo groups both showed a 
significant, though clinically small, decrease in hyperactivity from the pre-operative to 
the one-week assessments: Midazolam p= 0.04, placebo p=0.02, pooled data p=0.002 
[Midazolam baseline 2.03 (1.74), 1 week 1.68 (1.85); Placebo baseline 2.20 (1.61), 1 
week 1.64 (1.84)].  However,, there were no significant differences between the 
treatment groups, nor was there a significant effect of age. 
 
Prosocial Rutter Score: There was a significant improvement in pro social behaviours 
from pre-operative to week one assessments (p=0.002) [Midazolam baseline 15.5 
(3.37), 1 week 16.51 (3.12); Placebo baseline 14.76 (4.04), 1 week 15.69 (3.25)], but, 
again, there were neither significant between-group differences nor any significant 
effect of age. 
 
Dental attendance 
Table 4 shows the parents’ stated intention that their child would attend the Community 
Dental service for one, three and six-month follow-up compared to their actual 
attendance at the Clinic.  No differences were observed between the groups.   
 
Discussion 
The present study shows that 0.2mg/kg of transmucosal Midazolam did not improve the 
child’s behaviour at anaesthetic induction or reduce post-operative morbidity. However, 
midazolam pre-medication There was shown to reduce dental , however, a small but 
significant benefit in reducing anxiety in the most dentally anxious children.  Whilst the 
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difference was statistically significant, it is unclear whether so small a change relative 
to placebo would have clinical significance.    
 
The low dose of midazolam may be the reason for thisthese largely negative results, and 
further exacerbated by the fact that some of the midazolam might have been swallowed 
rather than absorbed transmucosally. The dose of 0.2mg/kg is lower than the normal 
oral dosage of 0.3mg/kg up to 1.0mg/kg.  However, whilst a higher dose of midazolam 
might have exerted more beneficial effects 22,  Ko Y P et al  have shown 0.2mg/kg to be 
effective in reducing emergence agitation and post-operative analgesic requirements 23.  
Moreover, Erlandsson et al  have reported this dose to be effective for conscious 
sedation of unco-operative paediatric dental patients 24.  Nevertheless, Calipel et al. 
reported that even 0.5mg/kg oral Midazolam premedication was not an effective 
premedicant even when compared to non pharmacological approaches 25.  
 
The authors had intended to administer a Midazolam dose of 0.3mg/kg but this was 
amended to 0.2mg/kg on the insistence of the ethics committee, whose rationale was to 
reduce the risks of respiratory depression and disinhibited behaviour, given the very 
short interval between anaesthesia and discharge in this type of ambulatory service. As 
such, any benefit to the child of a 0.3mg/kg dose for this ultra short procedure might 
have been outweighed by the known adverse cognitive side effects on discharge 26. 
Interestingly, our cognitive function data confirmed significant short-term impairment 
even at this low dose 10.  
 
The subjects in the present study reflect the type of child referred for dental extractions 
under general anaesthesia in Scotland in general and in this unit in particular 27, 28, 30. 
Few recruits dropped out of the study and there was little missing data, and, 
surprisingly, only one child refused the premed – from the placebo group.  On 
reflection, the results may have been influenced by the fact that both the RA and RN 
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were both women who were in constant, and emotionally supportive, contact with the 
child and parent throughout. This might have been an unwitting confounding factor that 
is, nevertheless, well recognised in the literature 29, 30. Thus, thisthe supportive 
environment may in itself have achieved an effective level of preparation 31, 32, to which 
the low dose of midazolam might have had little further to add.  A ‘placebo-effect’ was 
clearly evident in that almost half of the control group was observed to be drowsy, 
disorientated or asleep prior to anaesthetic induction.  
 
Midazolam was shown to improve post-operative dental anxiety in most anxious 
children. It is possible that the reduction in post-operative anxiety may be attibuted to 
the amnesic effect of the drug.  A previous controlled study, on the same population, 
confirmed that children self-reported significantly higher levels of dental anxiety post-
operatively 6 and so, thisthe present finding is important.  However, collecting self-
reported child anxiety data using with the MCDAS was a challenge in the present study.  
The subjects were young and  found to have littlethat, as  prior knowledge of local 
analgesia and sedation, their comprehension parts of the MCDAS was poor. were.  
Moreover, it was necessary for us to compute new MCDAS threshold values denoting 
“anxiety”Whilstrevised thresholdof to denote ‘anxiety’As a result, many participants 
failed to respond to all eight items and therefore an alternative method of analysing the 
scores was employed.  Data was thus converted into mean scores and similar cut-off 
points for dental anxiety were determined using previously published literature (e.g. 
Wong et al.13).  Whilst sound methods were used to translate the scores, as this is not 
yet validated,was derived in a logical way, our results should be interpreted with some 
caution.   
 
For the sample as a whole, the behaviour of children appeared to improve after the 
DGA visit, with less hyperactivity and more positive engagement with their parents.  
The reason for such a positive behaviour change is unclear and it must be borne in mind 
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that these improvements were clinically small in that the magnitude of the improvement 
was less than 10%.  The fact that post-operative emotional behaviour was better in the 
few children who were aged 8 years and above probably reflects their more advanced 
developmental level that confers greater understanding of the procedure and its effects, 
with consequent benefits to their coping.  This result is also consistent with evidence of 
a negative relationship between children’s age and disturbed behaviour and non-co-
operation 33, 34  and crying and restless behaviour after general anaesthesia 35. One might 
also speculate that, perhaps, the children felt better now that their toothache was 
alleviated; an alternative proposal might be that the children were concerned that if they 
misbehaved they would be sent for repeat treatment.  It could also be possible that 
children were relieved that the GA process was behind them.  
 
It could be argued that screening to exclude non-anxious subjects should have been 
performed prior to administration of a premedicant 36. However, the children in this 
sample were not undergoing ordinary elective surgical procedures; instead they had 
been referred for this radical treatment on account of their poor dental condition, 
toothache and likely pre-existing dental anxiety 6, 37.  The fact that the population in the 
present study had pre-operative Total Rutter Scores approaching the previously 
validated indicator for clinically significant disturbance is evidence of their poor pre-
operative behavioural and emotional state.  
 
Despite parental agreement to continue to attend for dental follow-up the results in this 
regard were disappointing, though not surprising given the previous dental history and 
social deprivation scores of the sample. It is possible that some parents preferred to 
attend their general dental practitioner. However, it is common for children have lapsed 
registration following the DGA event. 
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Overall, this This randomised placebo-controlled trial in children undergoing general 
anaesthesia for dental extractions has shown that 0.2mg/kg Midazolam  placed in the 
buccal pouch did not benefit dental anxiety generally, however the most dentally 
anxious children experienced a reduction in anxiety.  Behaviour at anaesthetic 
induction, postoperative psychological morbidity and subsequent dental attendance 
were not found to differ between the pre-medication groups.   
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Table 1 Observed Behaviour at Anaesthetic Induction 
*missing data on mask acceptance only: n=1  
Observed Behaviour                                        
(n=178) 
Placebo Midazolam 
Child’s willingness to sit on dental chair 
• Sits willingly on their own on dental chair  
• Sits reluctantly on dental chair with some 
encouragement 
• Sits on dental chair on parent’s knee  
• Parental physical restraint needed to hold patient on 
dental chair 
• Child refuses to sit on dental chair 
 
83 
4 
 
1 
 
1 
 
0 
 
85 
2 
 
2 
 
0 
 
0 
Rating for consciousness 
• Fully awake, alert 
• Drowsy, disorientated 
• Asleep 
 
47 
41 
1 
 
38 
51 
0 
Rating for movement 
• Violent movement interrupting treatment 
• Continuous movement making treatment difficult  
• Controllable movement that does not interfere with 
treatment 
• No movement 
 
5 
4 
18 
 
62 
 
3 
5 
18 
 
63 
Rating for crying 
• Hysterical crying that demands attention  
• Continuous, persistent crying that makes treatment 
difficult 
• Intermittent, mild crying that does not interfere with 
treatment 
• No crying 
 
3 
6 
 
9 
 
71 
 
2 
4 
 
9 
 
74 
Child's mask acceptance* 
• Willingly accepts mask   Accepts 
mask with some encouragement  
• Refuses to accept mask    
• Wants to hold mask themself   
• Initially accepts mask but gets distressed during 
induction 
 
78 
6 
2 
2 
 
0 
 
79 
7 
2 
0 
 
1 
Rating for overall behaviour 
• Aborted – no treatment rendered 
• Poor – treatment interrupted, only partial treatment 
complete 
• Fair – treatment interrupted, but eventually all 
completed 
• Good – difficult, but all treatment performed 
• Very good – some limited crying or movement, e.g. 
during anaesthesia or mouth prop insertion 
• Excellent – no crying or movement   
 
 
2 
0 
 
3 
 
6 
 
1860 
 
0 
1 
 
3 
 
7 
 
11 
67 
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Table 2. The Consort Flowchart 
       
 
 
 
 
 
 
 
Assessed for eligibility (n=504) 
Excluded       (n= 323) 
Not meeting inclusion criteria (n= 272) 
Refused to participate (n= 18) 
Other reasons (n=33) 
Analyzed (n= 90) 
Excluded from analysis (n= 1)  
Reasons:  Patient codes mixed up so 
excluded 
Lost to follow-up (n= 4) 
Reasons: 
General anaesthetic cancelled at last 
minute:   (n= 1) 
Lost to all contact (n= 3) 
 
Discontinued intervention (n= 0) 
     
Allocated to intervention (n= 91) 
Received allocated intervention (n= 91) 
Did not receive allocated intervention (n= 0) 
Lost to follow-up (n= 7) 
Reasons:  
Lost to all contact (n= 4) 
Refused GA (n= 2) 
Adverse event (contact dermatitis)  
(n= 1)* 
 
Discontinued intervention (n= 0) 
Allocated to intervention (n= 90) 
Received allocated intervention (n= 89) 
Did not receive allocated intervention (n= 1) 
 Reasons: child refused pre-medication* 
Analyzed (n= 89*) 
Excluded from analysis (n= 1) 
Reasons:  Patient codes mixed up so 
excluded 
* Subject was kept in study 
 
Allocation 
Analysis 
n=179 
Follow-Up 
Enrolment 
Randomised 
 Midazolam  Placebo 
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Table 3.  Demographic and clinical summary statistics 
 
_________________________________________________________________ 
Group   Midazolam (N = 90)  Placebo (N = 89) 
 
Age: years (s.d.)  6.52 (1.36)   6.54 (1.38)  
Sex: M/F   43/47    45/44 
 
Social deprivation category  
1 - 2     3      4 
3 - 5   32    28 
6 – 7   55    57 
 
Previous General anaesthesia 
None    70    66 
Dental    11         12 
Medical       6    10 
Medical and Dental   3      1 
 
Number of extractions 
2-5   28    32 
6-10   52    44 
11-16   10    12 
Missing data  0    1 
 
 
 
Table 4.  Children’s attendance at the Community Dental Service appointment 
 
(a) One Month Dental Attendance 
   Stated Intention    Actual Attendance 
   to attend    (having stated “Yes”) 
   YES  NO   YES  NO 
Midazolam: (n) 37  53   14  23 
Placebo: (n) 26  63   5  21  
 
   p = 0.13    p = 0.19 
_________________________________________________________________ 
(b) Three Month Dental Attendance 
   Stated Intention    Actual Attendance 
   to attend    (having stated “Yes”) 
   YES  NO   YES  NO 
Midazolam: (n) 36  54   15  21  
Placebo: (n) 24  65   8  16 
    
   p = 0.09    p = 0.70 
_________________________________________________________________ 
(c) Six Month Dental Attendance 
   Stated Intention    Actual Attendance 
   to attend    (having stated “Yes”) 
   YES  NO   YES  NO 
Midazolam: (n) 36  54   8  28 
Placebo: (n) 23  66   6  17 
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   p = 0.06    p = 0.98 
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